The Board remands the issue of entitlement to service connection for residuals of COVID-19 infection, including Guillain-Barré Syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP), for further development.
The deciding factor: Remand is necessary due to a duty to assist error in the AOJ's September 2024 rating decision, specifically regarding relevant service treatment records from December 2020 through June 2023 that were not considered by the AOJ.
- Claimed conditions
- Residuals of Coronavirus Disease 2019 infection (COVID-19), Guillain-Barré Syndrome, Chronic inflammatory demyelinating polyneuropathy (CIDP)
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 2, 2025
- Citation
- A25048497
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for service connection for Guillain-Barré Syndrome and entitlement to a TDIU on an extraschedular basis prior to October 20, 2016, due to insufficient compliance with previous remand directives.
- Remanded (sent back)
The Board remands the matter of entitlement to special monthly compensation (SMC) based on aid and attendance for an examination addressing whether the appellant requires regular aid and attendance due to his service-connected disabilities.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.